 |
Fludarabine phosphate oral tablets |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2007-12-18 00:00:00 |
| Sponsor | Sanofi-Aventis U.S., Inc.;55 Corproate Drive, P. O. Box 5925;Bridgewater, New Jersey, 08807 |
